Showing results (11-20 of 621) with videos related to

Sort By:
Pageof 63
Frontiers in Immunology|June 17, 2026
Severe cerebellitis as a manifestation of infliximab-associated overlap of neurosarcoidosis and myelin oligodendrocyte glycoprotein antibody-associated disease - case reportGregor Hütter, Maximilian Winkelhausen, Lars Tönges, et al.
Neurological Research and Practice|December 16, 2020
General principles and escalation options of immunotherapy in autoantibody-associated disorders of the CNSIlya Ayzenberg, Simon Faissner, Laura Tomaske, et al.
Cells|February 25, 2023
Prophylactic Glatiramer Acetate Treatment Positively Attenuates Spontaneous Opticospinal EncephalomyelitisÜmmügülsüm Koc, Steffen Haupeltshofer, Katharina Klöster, et al.
Therapeutic Advances in Neurological Disorders|November 12, 2015
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatmentSimon Faissner, Robert Hoepner, Carsten Lukas, et al.
Therapeutic Advances in Neurological Disorders|July 2, 2016
Immunoadsorption in patients with neuromyelitis optica spectrum disorderSimon Faissner, Johanna Nikolayczik, Andrew Chan, et al.
Frontiers in Immunology|May 20, 2021
Clozapine Regulates Microglia and Is Effective in Chronic Experimental Autoimmune EncephalomyelitisUlaş Ceylan, Steffen Haupeltshofer, Laura Kämper, et al.
Therapeutic Advances in Neurological Disorders|February 19, 2024
Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosisSimon Faissner, Marielena Bongert, Paulina Trendelenburg, et al.
Therapeutic Advances in Neurological Disorders|November 13, 2025
Chimeric antigen receptor T-cell therapy for stiff-person syndrome: bridging innovation and clinical challenges in neuroimmunologyJonathan Wickel, Jeremias Motte, Ilya Ayzenberg, et al.
Journal of Neurology|April 4, 2016
Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapsesSimon Faissner, Johanna Nikolayczik, Andrew Chan, et al.
Frontiers in Immunology|June 30, 2025
Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report seriesRegina Berkovich, Jonathan Calkwood, Heidi Crayton, et al.
Pageof 63